Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Shi

Showing results (1371-1380 of 1,428) with videos related to

Pageof 143
Sort By:
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Theranostics|August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk FactorsJia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular CarcinomaWei Guo, Yun-Fan Sun, Min-Na Shen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 2, 2009
[Studies on heredity rule of the first genealogy regarding fatal familial insomnia in Henan province]Jin Zhang, Jun Han, Xiao-Hong Shi, et al.
Plos One|February 6, 2014
Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysisQin Zhou, Fan Zhao, Ze-ping Lv, et al.
Cancer Letters|December 10, 2025
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib responseShi-Yu Zhang, De-Zhen Guo, Xin Zhang, et al.
Hepatology (Baltimore, Md.)|September 5, 2015
Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transitionLiu-Xiao Yang, Qiang Gao, Jie-Yi Shi, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P<sub>1</sub>) Modulators: Optimization of the PK, PD, and Safety ProfilesZili Xiao, Michael G Yang, T G Murali Dhar, et al.
Hepatology International|November 23, 2022
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Hai-Ying Zeng, et al.
BMC Cardiovascular Disorders|January 31, 2021
The long-term impact of a chronic total occlusion in a non-infarct-related artery on acute ST-segment elevation myocardial infarction after primary coronary interventionYu Liu, Le-Feng Wang, Xin-Chun Yang, et al.
Pageof 143

Showing results (1371-1380 of 1,428) with videos related to

Sort By:
Pageof 143
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Theranostics|August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk FactorsJia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular CarcinomaWei Guo, Yun-Fan Sun, Min-Na Shen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 2, 2009
[Studies on heredity rule of the first genealogy regarding fatal familial insomnia in Henan province]Jin Zhang, Jun Han, Xiao-Hong Shi, et al.
Plos One|February 6, 2014
Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysisQin Zhou, Fan Zhao, Ze-ping Lv, et al.
Cancer Letters|December 10, 2025
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib responseShi-Yu Zhang, De-Zhen Guo, Xin Zhang, et al.
Hepatology (Baltimore, Md.)|September 5, 2015
Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transitionLiu-Xiao Yang, Qiang Gao, Jie-Yi Shi, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P<sub>1</sub>) Modulators: Optimization of the PK, PD, and Safety ProfilesZili Xiao, Michael G Yang, T G Murali Dhar, et al.
Hepatology International|November 23, 2022
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Hai-Ying Zeng, et al.
BMC Cardiovascular Disorders|January 31, 2021
The long-term impact of a chronic total occlusion in a non-infarct-related artery on acute ST-segment elevation myocardial infarction after primary coronary interventionYu Liu, Le-Feng Wang, Xin-Chun Yang, et al.
Pageof 143